Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y Shirota

Showing results (11-20 of 32) with videos related to

Pageof 4
Sort By:
Hepatology (Baltimore, Md.)|March 7, 2001
Mutational analysis of the structure and functions of hepatitis C virus RNA-dependent RNA polymeraseW Qin, T Yamashita, Y Shirota, et al.
Annals of the Rheumatic Diseases|May 26, 2010
Peptide-based ELISAs are not sensitive and specific enough to detect muscarinic receptor type 3 autoantibodies in serum from patients with Sjogren's syndromeN Roescher, A Kingman, Y Shirota, et al.
The European Journal of Surgery = Acta Chirurgica|April 24, 2001
Is lymphadenectomy needed for all submucosal gastric cancers?H Yamada, Z Nihei, T Yamashita, et al.
Oncology (Williston Park, N.Y.)|December 1, 2000
UFT plus leucovorin for metastatic colorectal cancer: Japanese experienceW Ichikawa, Z Nihei, H Uetake, et al.
Clinical Colorectal Cancer|November 27, 2002
Thymidylate synthase gene expression in primary colorectal cancer and metastatic sitesH Yamada, W Ichikawa, H Uetake, et al.
The Journal of Biological Chemistry|May 16, 2000
Telomerase activity reconstituted in vitro with purified human telomerase reverse transcriptase and human telomerase RNA componentK Masutomi, S Kaneko, N Hayashi, et al.
The Journal of Biological Chemistry|June 23, 1998
RNA-dependent RNA polymerase activity of the soluble recombinant hepatitis C virus NS5B protein truncated at the C-terminal regionT Yamashita, S Kaneko, Y Shirota, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|June 1, 1996
[A case of nonresectable advanced gastric cancer responding to combined chemotherapy with 5'-DFUR, CDDP, and MMC]Y Tohyama, K Kojima, Y Shirota, et al.
British Journal of Cancer|October 17, 2003
Both gene expression for orotate phosphoribosyltransferase and its ratio to dihydropyrimidine dehydrogenase influence outcome following fluoropyrimidine-based chemotherapy for metastatic colorectal cancerW Ichikawa, H Uetake, Y Shirota, et al.
Nihon Rinsho Men'Eki Gakkai Kaishi = Japanese Journal of Clinical Immunology|April 20, 2000
[Three patients with systemic sclerosis complicated by microangiopathic hemolytic anemia and thrombocytopenia]A Mimori, H Nara, N Kaneko, et al.
Pageof 4

Showing results (11-20 of 32) with videos related to

Sort By:
Pageof 4
Hepatology (Baltimore, Md.)|March 7, 2001
Mutational analysis of the structure and functions of hepatitis C virus RNA-dependent RNA polymeraseW Qin, T Yamashita, Y Shirota, et al.
Annals of the Rheumatic Diseases|May 26, 2010
Peptide-based ELISAs are not sensitive and specific enough to detect muscarinic receptor type 3 autoantibodies in serum from patients with Sjogren's syndromeN Roescher, A Kingman, Y Shirota, et al.
The European Journal of Surgery = Acta Chirurgica|April 24, 2001
Is lymphadenectomy needed for all submucosal gastric cancers?H Yamada, Z Nihei, T Yamashita, et al.
Oncology (Williston Park, N.Y.)|December 1, 2000
UFT plus leucovorin for metastatic colorectal cancer: Japanese experienceW Ichikawa, Z Nihei, H Uetake, et al.
Clinical Colorectal Cancer|November 27, 2002
Thymidylate synthase gene expression in primary colorectal cancer and metastatic sitesH Yamada, W Ichikawa, H Uetake, et al.
The Journal of Biological Chemistry|May 16, 2000
Telomerase activity reconstituted in vitro with purified human telomerase reverse transcriptase and human telomerase RNA componentK Masutomi, S Kaneko, N Hayashi, et al.
The Journal of Biological Chemistry|June 23, 1998
RNA-dependent RNA polymerase activity of the soluble recombinant hepatitis C virus NS5B protein truncated at the C-terminal regionT Yamashita, S Kaneko, Y Shirota, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|June 1, 1996
[A case of nonresectable advanced gastric cancer responding to combined chemotherapy with 5'-DFUR, CDDP, and MMC]Y Tohyama, K Kojima, Y Shirota, et al.
British Journal of Cancer|October 17, 2003
Both gene expression for orotate phosphoribosyltransferase and its ratio to dihydropyrimidine dehydrogenase influence outcome following fluoropyrimidine-based chemotherapy for metastatic colorectal cancerW Ichikawa, H Uetake, Y Shirota, et al.
Nihon Rinsho Men'Eki Gakkai Kaishi = Japanese Journal of Clinical Immunology|April 20, 2000
[Three patients with systemic sclerosis complicated by microangiopathic hemolytic anemia and thrombocytopenia]A Mimori, H Nara, N Kaneko, et al.
Pageof 4